Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $10.7300 (-0.92%) ($10.3600 - $10.9000) on Thu. May. 9, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.93% (three month average) | RSI | 51 | Latest Price | $10.7300(-0.92%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -0.4% a day on average for past five trading days. | Weekly Trend | IOVA advances 0.4% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(49%) XBI(48%) ARKG(47%) IWO(43%) ARKK(41%) | Factors Impacting IOVA price | IOVA will decline at least -1.965% in a week (0% probabilities). VXX(-13%) VIXM(-8%) UUP(-7%) IFRA(-5%) TLT(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.965% (StdDev 3.93%) | Hourly BBV | 0 () | Intraday Trend | 0.9% | | | |
|
Resistance Level | $11.12 | 5 Day Moving Average | $11.08(-3.16%) | 10 Day Moving Average | $11.13(-3.59%) | 20 Day Moving Average | $11.12(-3.51%) | To recent high | -15.1% | To recent low | 14.4% | Market Cap | $1.571b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |